Table 3.
Predicted and actual sodium channel binding activities for novel grafted analogues forming the test set
![]() | |||||||
|---|---|---|---|---|---|---|---|
| Compound | R1 | R2 | LogPa | [3H]-BTX Inhibition at 40 μM (%) | −pIC50 |
||
| Obsd | Predb | Res | |||||
| 37 | n-Heptyl | Methyl | 3.6 | 83 ± 1.53 | -0.78 | -0.85 | -0.07 |
| 38 | Phenyl | H | 1.4 | 4 ± 4.56 | nd | -1.82 | |
| 39 | Phenyl | Methyl | 2.4 | 16 ± 5.23 | nd | -1.74 | |
| 40 | n-Nonyl | Methyl | 4.4 | 63 ± 1.01 | nd | -0.51 | |
| 41 | Phenyl | H | 1.6 | 50 ± 0.92 | -1.60 | -1.65 | -0.05 |
| 42 | Phenyl | Methyl | 2.5 | 49 ± 2.72 | -1.60 | -1.70 | -0.10 |
| 43 | n-Hexyl | Methyl | 3.3 | 68 ± 4.26 | nd | -1.09 | |
| 44 | n-Heptyl | Methyl | 3.7 | 71 ± 0.30 | -1.13 | -0.87 | -0.26 |
| 45 | n-Nonyl | Methyl | 4.5 | 69 ± 0.89 | nd | -0.59 | |
Calculated using the chemical properties tool of ChemDraw (CambridgeSoft, Inc.).
Data generated from the CoMFA non-cross-validated run (see QSAR methods).
